{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:41:35Z","timestamp":1793450495052,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001448-0"],"award-info":[{"award-number":["MOH-001448-0"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025KY558"],"award-info":[{"award-number":["2025KY558"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LMS26H160009"],"award-info":[{"award-number":["LMS26H160009"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007680","name":"Naval Medical Research Command","doi-asserted-by":"publisher","award":["CSASIMOH-001448-0"],"award-info":[{"award-number":["CSASIMOH-001448-0"]}],"id":[{"id":"10.13039\/100007680","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tranon.2026.102831","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T03:26:10Z","timestamp":1779938770000},"page":"102831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Therapeutic vaccines targeting solid tumors: A series of clinical trial analysis over the past decade"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7942-2035","authenticated-orcid":false,"given":"Fengqi","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4655-0206","authenticated-orcid":false,"given":"Darren Wan-Teck","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.102831_bib0001","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2026.102831_bib0002","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1158\/2159-8290.CD-18-1357","article-title":"Cancer vaccines: steering T cells down the right path to eradicate tumors","volume":"9","author":"Ott","year":"2019","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.tranon.2026.102831_bib0003","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1021\/jacs.2c10670","article-title":"Iterative design of ionizable lipids for intramuscular mRNA delivery","volume":"145","author":"Tilstra","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.tranon.2026.102831_bib0004","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1158\/2326-6066.CIR-24-0165","article-title":"Optimal neoantigen cancer vaccines target CD8+ and CD4+ T cells with multiple antigens","volume":"12","author":"Slingluff Jr","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.tranon.2026.102831_bib0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Sig. Transduct. Target Ther."},{"key":"10.1016\/j.tranon.2026.102831_bib0006","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41423-025-01316-4","article-title":"Eliciting antitumor immunity via therapeutic cancer vaccines","volume":"22","author":"Peng","year":"2025","journal-title":"Cell Mol. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102831_bib0007","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymthe.2023.10.024","article-title":"mRNA vaccines and their delivery strategies: a journey from infectious diseases to cancer","volume":"32","author":"Malla","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tranon.2026.102831_bib0008","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41568-025-00820-z","article-title":"Recent advances in therapeutic cancer vaccines","volume":"25","author":"Zaidi","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"7823","key":"10.1016\/j.tranon.2026.102831_bib0009","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","article-title":"An RNA vaccine drives immunity in melanoma","volume":"585","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2026.102831_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103369","article-title":"Evaluation of clinical and safety outcomes of cancer vaccines in patients with advanced non-small cell lung cancer after first-line therapy: a systematic review and meta-analysis","volume":"86","author":"Chen","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"17","key":"10.1016\/j.tranon.2026.102831_bib0011","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164258","article-title":"Linked CD4+\/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression","volume":"133","author":"Dolina","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.tranon.2026.102831_bib0012","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.tranon.2026.102831_bib0013","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/21645515.2015.1071455","article-title":"Safety and tolerability evaluation of the use of montanide ISA\u212251 as vaccine adjuvant: a systematic review","volume":"12","author":"van Doorn","year":"2016","journal-title":"Hum. Vaccin. ImmunOther"},{"issue":"12","key":"10.1016\/j.tranon.2026.102831_bib0014","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.tranon.2026.102831_bib0015","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.tranon.2026.102831_bib0016","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.autrev.2003.10.002","article-title":"T-cell vaccination in multiple sclerosis: update on clinical application and mode of action","volume":"3","author":"Hellings","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.tranon.2026.102831_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/srep15179","article-title":"Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis","volume":"5","author":"Shang","year":"2015","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.tranon.2026.102831_bib0018","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.3390\/ijms27094056","article-title":"ELISPOT as a functional for biomarker study in cancer immunotherapy: applications and future directions","volume":"27","author":"Fern\u00e1ndez Castro","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2026.102831_bib0019","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40425-017-0293-7","article-title":"Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response","volume":"5","author":"Xue","year":"2017","journal-title":"J. ImmunOther Cancer"},{"key":"10.1016\/j.tranon.2026.102831_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.106017","article-title":"Unbiased cell clustering analysis of vaccine-induced T cell responses in the imbokodo HIV-1 vaccine trial","volume":"122","author":"Voillet","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tranon.2026.102831_bib0021","article-title":"Harnessing TCR repertoires: predictive insights and therapeutic monitoring in cancer immunotherapy","volume":"28","author":"Chiffelle","year":"2025","journal-title":"Immunooncol. Technol."},{"issue":"10","key":"10.1016\/j.tranon.2026.102831_bib0022","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.tranon.2026.102831_bib0023","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41586-025-09539-1","article-title":"Proteotoxic stress response drives T cell exhaustion and immune evasion","volume":"647","author":"Wang","year":"2025","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.tranon.2026.102831_bib0024","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00502-24","article-title":"Predictive signatures of immune response to vaccination and implications of the immune setpoint remodeling","volume":"10","author":"Ramos","year":"2025","journal-title":"mSphere"},{"issue":"5","key":"10.1016\/j.tranon.2026.102831_bib0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2026.102831_bib0026","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-025-01263-1","article-title":"Synergistic effect of nucleoside modification and ionizable lipid composition on translation and immune responses to mRNA vaccines","volume":"10","author":"Danz","year":"2025","journal-title":"NPJ. Vaccines"},{"key":"10.1016\/j.tranon.2026.102831_bib0027","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41591-024-02851-9","article-title":"A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results","volume":"30","author":"Rappaport","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.tranon.2026.102831_bib0028","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","article-title":"RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer","volume":"639","author":"Sethna","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2026.102831_bib0029","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-024-01060-2","article-title":"A KIF20A-based thermosensitive hydrogel vaccine effectively potentiates immune checkpoint blockade therapy for hepatocellular carcinoma","volume":"10","author":"Zhao","year":"2025","journal-title":"NPJ. Vaccines"},{"key":"10.1016\/j.tranon.2026.102831_bib0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41541-022-00433-9","article-title":"Neoantigen cancer vaccine augments anti-CTLA-4 efficacy","volume":"7","author":"Salvatori","year":"2022","journal-title":"NPJ. Vaccines"},{"issue":"5","key":"10.1016\/j.tranon.2026.102831_bib0031","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/cancers16050981","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"16","author":"Hato","year":"2024","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.tranon.2026.102831_bib0032","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-025-01219-5","article-title":"Oncolytic virus-mediated p53 activation boosts the antitumor immunity of a p53-transduced dendritic cell vaccine","volume":"10","author":"Yamada","year":"2025","journal-title":"NPJ. Vaccines"},{"key":"10.1016\/j.tranon.2026.102831_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1498431","article-title":"DNA vaccines as promising immuno-therapeutics against cancer: a new insight","volume":"15","author":"Shariati","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102831_bib0034","article-title":"Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10432","key":"10.1016\/j.tranon.2026.102831_bib0035","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0140-6736(23)02444-3","article-title":"mRNA-based therapeutics: looking beyond COVID-19 vaccines","volume":"403","author":"Parhiz","year":"2024","journal-title":"Lancet"},{"issue":"51","key":"10.1016\/j.tranon.2026.102831_bib0036","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303261","article-title":"Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy","volume":"35","author":"Zong","year":"2023","journal-title":"Adv. Mater. Weinheim"},{"key":"10.1016\/j.tranon.2026.102831_bib0037","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41541-025-01132-x","article-title":"Targeting B7-H3 enhances the efficacy of neoantigen-based cancer vaccine in combination with radiotherapy","volume":"10","author":"Ke","year":"2025","journal-title":"NPJ. Vaccines"},{"key":"10.1016\/j.tranon.2026.102831_bib0038","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41590-023-01499-w","article-title":"High-dimensional analysis of 16 SARS-CoV-2 vaccine combinations reveals lymphocyte signatures correlating with immunogenicity","volume":"24","author":"Nu\u00f1ez","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tranon.2026.102831_bib0039","article-title":"AI-driven epitope prediction: a systematic review, comparative analysis, and practical guide for vaccine development","volume":"10","author":"Villanueva-Flores","year":"2025","journal-title":"NPJ. Vaccines"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:38:08Z","timestamp":1789112288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326001683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"alternative-id":["S1936523326001683"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102831","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic vaccines targeting solid tumors: A series of clinical trial analysis over the past decade","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102831"}}